Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $613.49 | 16 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Abbott Laboratories | $291.51 | 4 | $0 (2023) |
| Janssen Pharmaceuticals, Inc | $117.31 | 4 | $0 (2023) |
| Actelion Pharmaceuticals US, Inc. | $88.04 | 1 | $0 (2018) |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | $28.45 | 2 | $0 (2019) |
| BARD PERIPHERAL VASCULAR, INC. | $19.27 | 1 | $0 (2019) |
| Baxter Healthcare | $18.70 | 1 | $0 (2023) |
| Medtronic Vascular, Inc. | $18.20 | 1 | $0 (2020) |
| Novartis Pharmaceuticals Corporation | $17.22 | 1 | $0 (2018) |
| Siemens Medical Solutions USA, Inc. | $14.79 | 1 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2023 | $353.58 | 6 | Abbott Laboratories ($291.51) |
| 2020 | $18.20 | 1 | Medtronic Vascular, Inc. ($18.20) |
| 2019 | $83.18 | 4 | Janssen Pharmaceuticals, Inc ($47.57) |
| 2018 | $132.16 | 4 | Actelion Pharmaceuticals US, Inc. ($88.04) |
| 2017 | $26.37 | 1 | Janssen Pharmaceuticals, Inc ($26.37) |
All Payment Transactions
16 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/13/2023 | Baxter Healthcare | Hillrom - Cardiac Ambulatory Monitor (Device) | Food and Beverage | In-kind items and services | $18.70 | General |
| Category: Cardiac Arrhythmia Monitoring | ||||||
| 05/26/2023 | Abbott Laboratories | MITRACLIP (Device) | Food and Beverage | In-kind items and services | $24.21 | General |
| Category: Vascular | ||||||
| 04/04/2023 | Abbott Laboratories | MITRACLIP (Device) | Food and Beverage | In-kind items and services | $121.48 | General |
| Category: Vascular | ||||||
| 04/04/2023 | Abbott Laboratories | MITRACLIP (Device) | Food and Beverage | In-kind items and services | $121.48 | General |
| Category: Vascular | ||||||
| 04/04/2023 | Abbott Laboratories | MITRACLIP (Device) | Food and Beverage | In-kind items and services | $24.34 | General |
| Category: Vascular | ||||||
| 03/30/2023 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $43.37 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 11/16/2020 | Medtronic Vascular, Inc. | CoreValve Evolut (Device) | Food and Beverage | In-kind items and services | $18.20 | General |
| Category: Transcatheter Valve Systems | ||||||
| 10/21/2019 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $16.34 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 07/29/2019 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $28.54 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 04/10/2019 | BARD PERIPHERAL VASCULAR, INC. | — | Food and Beverage | In-kind items and services | $19.27 | General |
| 02/27/2019 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $19.03 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 05/29/2018 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $12.11 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 04/23/2018 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $17.22 | General |
| Category: CARDIOVASCULAR | ||||||
| 04/18/2018 | Actelion Pharmaceuticals US, Inc. | — | Food and Beverage | In-kind items and services | $88.04 | General |
| 02/14/2018 | Siemens Medical Solutions USA, Inc. | SPECT Symbia Intevo (Device) | Food and Beverage | In-kind items and services | $14.79 | General |
| Category: MI - Nuclear Medicine (incl. PETNET & MIBR) | ||||||
| 09/25/2017 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $26.37 | General |
| Category: Cardiovascular & Metabolism | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 25 | 2,607 | 2,853 | $497,435 | $107,603 |
| 2022 | 25 | 2,327 | 2,617 | $454,333 | $110,511 |
| 2021 | 27 | 2,746 | 3,096 | $487,681 | $127,539 |
| 2020 | 26 | 2,734 | 3,052 | $426,690 | $115,781 |
All Medicare Procedures & Services
143 procedure records from CMS Medicare Utilization — Page 1 of 6
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 210 | 256 | $77,504 | $18,636 | 24.0% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Facility | 2023 | 363 | 367 | $86,979 | $17,912 | 20.6% |
| 78452 | Nuclear medicine studies of heart muscle at rest and with stress and spect | Office | 2023 | 42 | 51 | $33,940 | $8,116 | 23.9% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Office | 2023 | 123 | 129 | $42,515 | $6,942 | 16.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 71 | 78 | $31,044 | $6,183 | 19.9% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 43 | 59 | $18,408 | $5,587 | 30.4% |
| 78452 | Nuclear medicine studies of heart muscle at rest and with stress and spect | Facility | 2023 | 97 | 97 | $23,086 | $4,837 | 21.0% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 30 | 31 | $18,693 | $4,150 | 22.2% |
| 93010 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | Facility | 2023 | 570 | 652 | $18,256 | $3,616 | 19.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2023 | 77 | 77 | $16,016 | $3,562 | 22.2% |
| J2785 | Injection, regadenoson, 0.1 mg | Office | 2023 | 23 | 92 | $14,210 | $3,403 | 23.9% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Facility | 2023 | 41 | 41 | $17,179 | $3,382 | 19.7% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 25 | 25 | $12,925 | $3,097 | 24.0% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 29 | 29 | $11,919 | $2,920 | 24.5% |
| 93248 | Heart rhythm review and interpretation of continous external ekg over 8-15 days | Facility | 2023 | 133 | 133 | $12,103 | $2,445 | 20.2% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Facility | 2023 | 28 | 28 | $7,168 | $1,655 | 23.1% |
| 93016 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | Facility | 2023 | 91 | 91 | $6,643 | $1,382 | 20.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 18 | 18 | $5,076 | $1,099 | 21.7% |
| 93018 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | Facility | 2023 | 114 | 115 | $5,635 | $1,042 | 18.5% |
| 92960 | External shock to heart to regulate heart beat | Facility | 2023 | 12 | 12 | $4,440 | $1,039 | 23.4% |
| 93244 | Heart rhythm review, and interpretation of continous external ekg over more than 48 hours up to 7 days | Facility | 2023 | 50 | 51 | $4,233 | $902.40 | 21.3% |
| 93312 | Ultrasound of heart with probe in esophagus, with report | Facility | 2023 | 12 | 12 | $4,368 | $850.60 | 19.5% |
| 93017 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) | Office | 2023 | 36 | 36 | $4,716 | $840.27 | 17.8% |
| 93308 | Ultrasound of heart, follow-up | Facility | 2023 | 44 | 45 | $3,825 | $810.95 | 21.2% |
| 93280 | Programming of dual lead pacemaker system | Office | 2023 | 21 | 21 | $3,213 | $674.25 | 21.0% |
About Dr. Jonathan Bolles, MD
Dr. Jonathan Bolles, MD is a Cardiovascular Disease healthcare provider based in Wenatchee, Washington. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/25/2006. The National Provider Identifier (NPI) number assigned to this provider is 1003839093.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Jonathan Bolles, MD has received a total of $613.49 in payments from pharmaceutical and medical device companies, with $353.58 received in 2023. These payments were reported across 16 transactions from 9 companies. The most common payment nature is "Food and Beverage" ($613.49).
As a Medicare-enrolled provider, Bolles has provided services to 10,414 Medicare beneficiaries, totaling 11,618 services with total Medicare billing of $461,434. Data is available for 4 years (2020–2023), covering 143 distinct procedure/service records.
Practice Information
- Specialty Cardiovascular Disease
- Other Specialties Cardiovascular Disease
- Location Wenatchee, WA
- Active Since 07/25/2006
- Last Updated 07/14/2015
- Taxonomy Code 207RC0000X
- Entity Type Individual
- NPI Number 1003839093
Products in Payments
- MITRACLIP (Device) $291.51
- XARELTO (Drug) $117.31
- LifeVest (Device) $28.45
- Hillrom - Cardiac Ambulatory Monitor (Device) $18.70
- CoreValve Evolut (Device) $18.20
- ENTRESTO (Drug) $17.22
- SPECT Symbia Intevo (Device) $14.79
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Cardiovascular Disease Doctors in Wenatchee
Felix Krainski, M.d, M.D
Cardiovascular Disease — Payments: $24,797
Roy Lin, M.d, M.D
Cardiovascular Disease — Payments: $14,414
Dr. Gautam Nayak, M.d, M.D
Cardiovascular Disease — Payments: $12,107
Dr. Matthew Newman, Md, MD
Cardiovascular Disease — Payments: $1,234
Kathleen Love, Md, MD
Cardiovascular Disease — Payments: $1,208
William Murray, Md, MD
Cardiovascular Disease — Payments: $712.84